Literature DB >> 25083533

Reply to ‘Evidence for harm, comment on . . .’ by Kripke & Langer.

Anton Pottegård, Søren Friis, Morten Andersen, Jesper Hallas.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25083533      PMCID: PMC4168394          DOI: 10.1111/bcp.12271

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Utilization of hypnotic medication in the context of cancer: predictors and frequency of use.

Authors:  Lucie Casault; Josée Savard; Hans Ivers; Marie-Hélène Savard; Sébastien Simard
Journal:  Support Care Cancer       Date:  2011-06-03       Impact factor: 3.603

2.  Smoking and the consumption of antidepressants, anxiolytics and hypnotic drugs: results of a large, French epidemiological study in 2005.

Authors:  Marie Chéron-Launay; Anne-Laurence Le Faou; Christine Sévilla-Dedieu; Fabien Gilbert; Viviane Kovess-Masfety
Journal:  Addict Behav       Date:  2011-03-01       Impact factor: 3.913

Review 3.  Immortal time bias in pharmaco-epidemiology.

Authors:  Samy Suissa
Journal:  Am J Epidemiol       Date:  2007-12-03       Impact factor: 4.897

Review 4.  Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits.

Authors:  Jennifer Glass; Krista L Lanctôt; Nathan Herrmann; Beth A Sproule; Usoa E Busto
Journal:  BMJ       Date:  2005-11-11

5.  A general population survey on patterns of benzodiazepine use and dependence in Lebanon.

Authors:  W J Naja; A Pelissolo; R S Haddad; R Baddoura; C Baddoura
Journal:  Acta Psychiatr Scand       Date:  2000-12       Impact factor: 6.392

6.  Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study.

Authors:  Anton Pottegård; Søren Friis; Morten Andersen; Jesper Hallas
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

7.  Evidence for harm, comment on ‘Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study’.

Authors:  Daniel F Kripke; Robert D Langer
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

8.  Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study.

Authors:  Chia-Hung Kao; Li-Min Sun; Ji-An Liang; Shih-Ni Chang; Fung-Chang Sung; Chih-Hsin Muo
Journal:  Mayo Clin Proc       Date:  2012-05       Impact factor: 7.616

9.  Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan.

Authors:  Chia-Hung Kao; Li-Min Sun; Kuan-Pin Su; Shih-Ni Chang; Fung-Chang Sung; Chih-Hsin Muo; Ji-An Liang
Journal:  J Clin Psychiatry       Date:  2012-04       Impact factor: 4.384

10.  Hypnotics' association with mortality or cancer: a matched cohort study.

Authors:  Daniel F Kripke; Robert D Langer; Lawrence E Kline
Journal:  BMJ Open       Date:  2012-02-27       Impact factor: 2.692

  10 in total
  1 in total

1.  External adjustment of unmeasured confounders in a case-control study of benzodiazepine use and cancer risk.

Authors:  Lau Caspar Thygesen; Anton Pottegård; Annette Kjaer Ersbøll; Søren Friis; Til Stürmer; Jesper Hallas
Journal:  Br J Clin Pharmacol       Date:  2017-07-12       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.